After ousting CEO, Novo Nordisk reclaims crown as largest European company

Dow Jones

06/13

MW After ousting CEO, Novo Nordisk reclaims crown as largest European company

By Steve Goldstein

Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization.

Novo Nordisk's ADR $(NVO)$ (DK:NOVO.B), at Thursday's close, valued the drugmaker at $357.9 billion, while SAP $(SAP)$ (XE:SAP), the German software company, is worth $353 billion.

Last month, Novo Nordisk said Lars Fruergaard Jørgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped.

Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares.

The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO.

-Steve Goldstein

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

June 13, 2025 04:48 ET (08:48 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2543509250"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2543509250\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2543509250?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-13 16:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2543509250","market":"sh","top_or_hot":-1,"title":"After ousting CEO, Novo Nordisk reclaims crown as largest European company","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW After ousting CEO, Novo Nordisk reclaims crown as largest European company\n</p>\n<p>\n  By Steve Goldstein \n</p>\n<p>\n     Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization. \n</p>\n<p>\n     Novo Nordisk's ADR <a href=\"https://laohu8.com/S/NVO\">$(NVO)$</a> (DK:NOVO.B), at Thursday's close, valued the drugmaker at $357.9 billion, while SAP <a href=\"https://laohu8.com/S/SAP\">$(SAP)$</a> (XE:SAP), the German software company, is worth $353 billion. \n</p>\n<p>\n     Last month, Novo Nordisk said Lars Fruergaard Jørgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped. \n</p>\n<p>\n     Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares. \n</p>\n<p>\n     The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO. \n</p>\n<p>\n     -Steve Goldstein \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 13, 2025 04:48 ET (08:48 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After ousting CEO, Novo Nordisk reclaims crown as largest European company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter ousting CEO, Novo Nordisk reclaims crown as largest European company\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-06-13 16:48</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW After ousting CEO, Novo Nordisk reclaims crown as largest European company\n</p>\n<p>\n  By Steve Goldstein \n</p>\n<p>\n     Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization. \n</p>\n<p>\n     Novo Nordisk's ADR <a href=\"https://laohu8.com/S/NVO\">$(NVO)$</a> (DK:NOVO.B), at Thursday's close, valued the drugmaker at $357.9 billion, while SAP <a href=\"https://laohu8.com/S/SAP\">$(SAP)$</a> (XE:SAP), the German software company, is worth $353 billion. \n</p>\n<p>\n     Last month, Novo Nordisk said Lars Fruergaard Jørgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped. \n</p>\n<p>\n     Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares. \n</p>\n<p>\n     The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO. \n</p>\n<p>\n     -Steve Goldstein \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 13, 2025 04:48 ET (08:48 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"NVO","symbol_name":"諾和諾德","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2543509250","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2543509250","pubTimestamp":1749804480,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization.Novo Nordisk's ADR  , at Thursday's close, valued the drugmaker at $357.9 billion, while SAP  , the German software company, is worth $353 billion.Last month, Novo Nordisk said Lars Fruergaard Jrgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped.Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares.The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independent","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"NVO":"诺和诺德","BK4613":"AI应用软件","BK4023":"应用软件","BK4585":"ETF&股票定投概念","SAP":"SAP SE","BK4532":"文艺复兴科技持仓","BK4588":"碎股","BK4599":"减肥药","LU0154236417.USD":"BGF US FLEXIBLE EQUITY \"A2\" ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","BK4007":"制药","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4528":"SaaS概念"},"translate_title":"罢免首席执行官后，诺和诺德重新夺回欧洲最大公司桂冠","themeId":"4d217f261842c16c97637fa9633c3863","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NVO":1,"SAP":0.9},"content_text":"MW After ousting CEO, Novo Nordisk reclaims crown as largest European company\n\n\n  By Steve Goldstein \n\n\n     Novo Nordisk's shock decision to oust its chief executive has resulted in the Ozempic maker once again becoming Europe's largest by market capitalization. \n\n\n     Novo Nordisk's ADR $(NVO)$ (DK:NOVO.B), at Thursday's close, valued the drugmaker at $357.9 billion, while SAP $(SAP)$ (XE:SAP), the German software company, is worth $353 billion. \n\n\n     Last month, Novo Nordisk said Lars Fruergaard Jørgensen was stepping down after eight years running the company, after the charitable foundation that is its main owner called for change. Novo Nordisk's stock had faltered as it encountered competition from rival Eli Lilly and a key developmental drug didn't perform as well at a trial as hoped. \n\n\n     Though not immediately, that move to push out its CEO sparked a 28% rally in the Copenhagen-listed shares. \n\n\n     The Financial Times has reported that an activist investor, Parvus, was building a stake to help influence the appointment of a new CEO. \n\n\n     -Steve Goldstein \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 13, 2025 04:48 ET (08:48 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}